Sangamo Biosciences, Inc.

Sangamo Biosciences, Inc. is a clinical-stage biotechnology company focused on developing genomic medicines to treat patients with genomic diseases. With advanced technologies like gene therapy and gene editing, Sangamo aims to provide novel solutions for genetic disorders, cancer, and other diseases. The companys research and development efforts are primarily focused on three areas: gene therapy, ex vivo cell therapy, and in vivo genome editing. By leveraging its proprietary platform, Sangamo Biosciences strives to revolutionize the treatment of various genetic conditions.